Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytotoxicity and genotoxicity of sulfur-vegetable oil polymers and urea‑loaded composites evaluated by the Allium cepa test.

Environmental science and pollution research international·2026
Same author

Cornstarch-Derived ZnO Nanoparticles: A Promising Antimicrobial Agent Against <i>Pseudomonas aeruginosa</i>.

Current topics in medicinal chemistry·2026
Same author

Designing Polymeric Multifunctional Nanogels for Photothermal Inactivation: Exploiting Conjugate Polymers and Thermoresponsive Platforms.

Pharmaceutics·2025
Same author

Natural photosensitizers in photodynamic therapy: In vitro activity against monolayers and spheroids of human colorectal adenocarcinoma SW480 cells.

Photodiagnosis and photodynamic therapy·2020
Same author

Photodynamic Modulation of Type 1 Interferon Pathway on Melanoma Cells Promotes Dendritic Cell Activation.

Frontiers in immunology·2019
Same author

Secretome profiling of heterotypic spheroids suggests a role of fibroblasts in HIF-1 pathway modulation and colorectal cancer photodynamic resistance.

Cellular oncology (Dordrecht, Netherlands)·2019

Related Experiment Video

Updated: May 18, 2026

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
11:04

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model

Published on: January 13, 2023

Comparative photodynamic therapy study using two phthalocyanine derivatives.

Edith Inés Yslas1, Laura Natalia Milla, Silvia Romanini

  • 1Departments of Molecular Biology ; Chemistry, and.

Experimental and Therapeutic Medicine
|September 21, 2012
PubMed
Summary

This study compared two phthalocyanine derivatives for photodynamic therapy (PDT) in a mouse tumor model. ZnPc(OCH(3))(4)-PDT showed a higher success rate in tumor ablation compared to ZnPc(CF(3))(4)-PDT.

More Related Videos

In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology
13:17

In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology

Published on: September 29, 2023

Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers
09:45

Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers

Published on: October 28, 2015

Related Experiment Videos

Last Updated: May 18, 2026

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
11:04

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model

Published on: January 13, 2023

In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology
13:17

In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology

Published on: September 29, 2023

Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers
09:45

Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers

Published on: October 28, 2015

Area of Science:

  • Biomedical Engineering
  • Photochemistry
  • Oncology

Background:

  • Photodynamic therapy (PDT) is a promising cancer treatment modality.
  • Phthalocyanine derivatives are effective photosensitizers used in PDT.
  • Evaluating novel phthalocyanine derivatives is crucial for advancing PDT efficacy.

Purpose of the Study:

  • To compare the photodynamic efficacy of two phthalocyanine derivatives, ZnPc(OCH(3))(4) and ZnPc(CF(3))(4).
  • To assess the tumor ablation capabilities of these derivatives in a mouse tumor model.
  • To evaluate the potential of these compounds as therapeutic agents for small tumors.

Main Methods:

  • A comparative photodynamic therapy (PDT) study was conducted using ZnPc(OCH(3))(4) and ZnPc(CF(3))(4) in a mouse tumor model.
  • Mice bearing LM2 mouse mammary adenocarcinoma received intraperitoneal injections of the phthalocyanine derivatives at 0.2 mg/kg.
  • Tumor regression and cell death were analyzed post-PDT (210 J/cm(2)), with histological and biochemical assessments for toxicity.

Main Results:

  • Both ZnPc(OCH(3))(4)-PDT and ZnPc(CF(3))(4)-PDT demonstrated the ability to induce tumor ablation.
  • ZnPc(OCH(3))(4)-PDT exhibited a higher success rate in cytotoxic effect and tumor regression compared to ZnPc(CF(3))(4)-PDT.
  • No significant hepatic or renal toxicity was indicated by histological examination and serum biochemical parameters.

Conclusions:

  • ZnPc(OCH(3))(4)-PDT and ZnPc(CF(3))(4)-PDT are feasible treatment options for small tumors.
  • ZnPc(OCH(3))(4) demonstrates superior photodynamic efficacy over ZnPc(CF(3))(4) in this preclinical model.
  • Further research into phthalocyanine derivatives holds potential for enhanced PDT cancer treatments.